Page 524 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 524

444    Part IV  Disorders of Hematopoietic Cell Development


        Lindqvist H, Carlsson G, Moell J, et al: Neutropenia in childhood: a 5-year   Staley EM, Schwartz J, Pham HP: An update on ABO incompatible hema-
           experience at a tertiary center. Eur J Pediatr 2015174:6, 2014.  topoietic progenitor cell transplantation. Transfus Apher Sci 54:337–344,
        Loughran TP, Jr, Zickl L, Olson TL, et al: Immunosuppressive therapy of   2016.
           LGL  leukemia:  prospective  multicenter  phase  II  study  by  the  Eastern   Steinway SN, Leblanc F, Loughran TP: The pathogenesis and treatment of
           Cooperative Oncology Group (E5998).                   large granular lymphocyte leukemia. Blood Rev 28:87–94, 2014.
        Lown R, Rhodes E, Bosworth J, et al: Acquired amegakaryocytic thrombo-  Velegraki  M,  Koutala  H,  Tsatsanis  C,  et al:  Increased  levels  of  the  high
           cytopenia: potential role of thrombopoietin receptor agonists. Clin Adv   mobility  group  box  1  protein  sustain  the  inflammatory  bone  marrow
           Hematol Oncol 8:809–812, 2010.                        microenvironment  in  patients  with  chronic  idiopathic  neutropenia  via
        Malphettes M, Gérard L, Galicier L, et al: Good syndrome: an adult-onset   activation of toll-like receptor 4. J Clin Immunol 32:312, 2012.
           immunodeficiency remarkable for its high incidence of invasive infections   Visco C, Barcellini W, Maura F, et al: Autoimmune cytopenias in chronic
           and autoimmune complications. Clin Infect Dis 15:61, 2015.  lymphocytic leukemia. Am J Hematol 89:1055–1062, 2014.
        Newburger  PE,  Dale  DC:  Evaluation  and  management  of  patients  with   Worel N: ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplan-
           isolated neutropenia. Semin Hematol 50:198–206, 2013.  tation. Transfus Med Hemother 43:3–12, 2016.
        Pavlaki KI, Kastrinaki MC, Klontzas M, et al: Abnormal telomere shortening   Zelenetz AD: Guidelines for NHL: updates to the management of diffuse
           of peripheral blood mononuclear cells and granulocytes in patients with   large B-cell lymphoma and new guidelines for primary cutaneous CD30+
           chronic idiopathic neutropenia. Haematologica 97:5, 2012.  T-cell lymphoproliferative disorders and T-cell large granular lymphocytic
        Rajala HL, Eldfors S, Kuusanmäki H, et al: Discovery of somatic STAT5b   leukemia. J Natl Compr Canc Netw 12:797–800, 2014.
           mutations in large granular lymphocytic leukemia. Blood 121(22):2013.  Zent CS, Ding W, Reinalda MS, et al: Autoimmune cytopenia in chronic
        Rajala HL, Olson T, Clemente MJ, et al: The analysis of clonal diversity and   lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical
           therapy responses using STAT3 mutations as a molecular marker in large   presentation and prognosis. Leuk Lymphoma 50:8, 2009.
           granular lymphocytic leukemia. Haematologica 100:91–99, 2015.
        Sicre de Fontbrune F, Moignet A, Beaupain B, et al: Severe chronic primary
           neutropenia in adults: report on a series of 108 patients. Blood 126:14,   REFERENCES
           2015.
        Spanoudakis M, Koutala H, Ximeri M, et al: T-cell receptor Vβ repertoire   For the complete list of references, log on to www.expertconsult.com.
           analysis  in  patients  with  chronic  idiopathic  neutropenia  demonstrates
           the presence of aberrant T-cell expansions. Clin Immunol 137:384, 2010.
   519   520   521   522   523   524   525   526   527   528   529